Ian Hardy, Ph.D.

Ian Hardy, Ph.D., is Vice President of Chemistry, Manufacturing & Controls (CMC) for Deerfield Discovery and Development, and joined Deerfield in 2019. He is responsible for leading CMC development, manufacturing and supply chain activities for all therapeutic modalities for Deerfield’s academic translator companies and some early stage portfolio companies. Dr. Hardy has over 25 years of industry experience leading CMC development activities from preclinical through commercialization and lifecycle management in both large pharma at GlaxoSmithKline, AstraZeneca and Merck, as well as emerging biopharmaceutical companies, most recently Lycera. Dr. Hardy holds a Ph.D. degree in Pharmaceutics from the University of Nottingham and an M.B.A. from Warwick Business School.